Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range.
Hypercalcemia
Intact PTH
Ionised calcium
Parathyroid adenoma
Primary hyperparathyroidism
Journal
BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567
Informations de publication
Date de publication:
24 Apr 2019
24 Apr 2019
Historique:
entrez:
11
5
2019
pubmed:
11
5
2019
medline:
3
7
2019
Statut:
epublish
Résumé
Primary hyperparathyroidism is a common endocrine disorder. Hypercalcemia with normal PTH levels is very unusual and can lead to diagnostic difficulties. There are very few very few studies in the literature and all with limited numerical samples. The goal of the present study was to determine the real incidence and characteristics of primary hyperparathyroidism with normal PTH and to evaluate if intraoperative PTH testing is useful in these patients. We performed a retrospective review of 314 patients who had undergone parathyroidectomy to treat primary hyperparathyroidism between January 2002 and December 2016. Patients were divided in two groups according to biochemical preoperative findings: in Group A were included patients with normal serum PTH, in Group B those with increased serum PTH. Nine patients (3.7%) were included in group A and 235 in group B. Patients in group A were younger (51.5 ± 12.9 years vs 59.6 ± 12.5); preoperative serum calcium and the incidence of coexisting thyroid disease were similar between the two groups. Symptomatic patients were more frequent in Group A (77.8% vs 39.1%; p = 0.048). There were no significant differences regarding preoperative localization studies and surgical procedure. Intraoperative PTH determination demonstrated sensitivity of 86% in group A and 97% in group B, specificity and positive predictive value of 100% in both the groups, negative predictive value of 67% in group A and 79% in group B. Histopathological examination demonstrated a single gland disease in 8 (88.9%) patients in group A and a multi gland disease in 1 (11.1%), in group B single gland disease was found in 218 (92.8%) patients and multi gland disease in 17 (7.2%). Unsuccessful surgery with persistent or recurrent hyperparathyroidism occurred in 1 (11.1%) patient in group A and 4 (1.7%) in group B. Primary hyperparathyroidism with normal PTH is rare but physicians should be aware of this possibility in patients with hypercalcaemia. Patients with normal PTH levels are younger and more frequently symptomatic. Intraoperative PTH testing plays an important role in the operative management even in such patients.
Sections du résumé
BACKGROUND
BACKGROUND
Primary hyperparathyroidism is a common endocrine disorder. Hypercalcemia with normal PTH levels is very unusual and can lead to diagnostic difficulties. There are very few very few studies in the literature and all with limited numerical samples. The goal of the present study was to determine the real incidence and characteristics of primary hyperparathyroidism with normal PTH and to evaluate if intraoperative PTH testing is useful in these patients.
METHODS
METHODS
We performed a retrospective review of 314 patients who had undergone parathyroidectomy to treat primary hyperparathyroidism between January 2002 and December 2016. Patients were divided in two groups according to biochemical preoperative findings: in Group A were included patients with normal serum PTH, in Group B those with increased serum PTH.
RESULTS
RESULTS
Nine patients (3.7%) were included in group A and 235 in group B. Patients in group A were younger (51.5 ± 12.9 years vs 59.6 ± 12.5); preoperative serum calcium and the incidence of coexisting thyroid disease were similar between the two groups. Symptomatic patients were more frequent in Group A (77.8% vs 39.1%; p = 0.048). There were no significant differences regarding preoperative localization studies and surgical procedure. Intraoperative PTH determination demonstrated sensitivity of 86% in group A and 97% in group B, specificity and positive predictive value of 100% in both the groups, negative predictive value of 67% in group A and 79% in group B. Histopathological examination demonstrated a single gland disease in 8 (88.9%) patients in group A and a multi gland disease in 1 (11.1%), in group B single gland disease was found in 218 (92.8%) patients and multi gland disease in 17 (7.2%). Unsuccessful surgery with persistent or recurrent hyperparathyroidism occurred in 1 (11.1%) patient in group A and 4 (1.7%) in group B.
CONCLUSIONS
CONCLUSIONS
Primary hyperparathyroidism with normal PTH is rare but physicians should be aware of this possibility in patients with hypercalcaemia. Patients with normal PTH levels are younger and more frequently symptomatic. Intraoperative PTH testing plays an important role in the operative management even in such patients.
Identifiants
pubmed: 31074404
doi: 10.1186/s12893-018-0459-3
pii: 10.1186/s12893-018-0459-3
pmc: PMC7402568
doi:
Substances chimiques
Parathyroid Hormone
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
124Références
Endocrine. 2009 Apr;35(2):147-50
pubmed: 19116787
Surgery. 1991 Jul;110(1):47-53
pubmed: 1907770
Updates Surg. 2016 Jun;68(2):155-61
pubmed: 26826082
J Clin Endocrinol Metab. 2006 Oct;91(10):3826-9
pubmed: 16849415
Transplant Proc. 2007 Jul-Aug;39(6):1775-8
pubmed: 17692609
Surgery. 2011 Dec;150(6):1102-12
pubmed: 22136828
Clin Med Insights Endocrinol Diabetes. 2013 Oct 23;6:63-7
pubmed: 24250241
Am J Med. 1991 Nov;91(5):547-8
pubmed: 1951417
South Med J. 2001 Mar;94(3):339-41
pubmed: 11284524
Aging Clin Exp Res. 2017 Feb;29(Suppl 1):29-33
pubmed: 27832469
World J Surg. 2003 Apr;27(4):481-5
pubmed: 12658497
Eur J Endocrinol. 2016 Jan;174(1):D1-8
pubmed: 26340967
Minerva Chir. 2012 Aug;67(4):337-42
pubmed: 23022758
QJM. 2000 Jun;93(6):365-7
pubmed: 10873186
G Chir. 2010 Jun-Jul;31(6-7):322-4
pubmed: 20646383
Endocr Pract. 2011 May-Jun;17(3):384-94
pubmed: 21134884
World J Surg Oncol. 2008 Feb 21;6:24
pubmed: 18291038
Med J Aust. 1996 Aug 19;165(4):197-8
pubmed: 8773648
Int J Surg. 2016 Jan;25:82-7
pubmed: 26646659
Clin Endocrinol (Oxf). 2008 Sep;69(3):382-5
pubmed: 18284640
Aust N Z J Med. 1998 Apr;28(2):173-8
pubmed: 9612524
Ann Surg Oncol. 2011 Nov;18(12):3437-42
pubmed: 21537864
N Engl J Med. 2008 Sep 11;359(11):1184-6
pubmed: 18784115
Eur J Endocrinol. 2012 Dec 10;168(1):49-58
pubmed: 23093696
World J Surg. 2011 Sep;35(9):2006-9
pubmed: 21713573
BMC Surg. 2013 Sep 18;13:36
pubmed: 24044556
J Clin Endocrinol Metab. 2011 Aug;96(8):2325-9
pubmed: 21593105
World J Surg. 2017 Jun;41(6):1649-1650
pubmed: 28097408